Multiple sclerosis: open trials in Austria

9 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
Medizinische Universitaet Innsbruck, Innsbruck
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-10-27
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Innsbruck · Novartis Investigative Site, Linz · Novartis Investigative Site, Vienna
Registry updated 2026-10-13
NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Trial Treatment · Phase 3 · Sanofi
Medizinische Universitaet Innsbruck, Innsbruck · Neurologisch, AO. Univ. Prof. Dr. Fritz Leutmezer, Wien
Registry updated 2026-10-13
2024-511686-11-00
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Medical University of Vienna, Vienna
Registry updated 2026-09-29
2024-512707-40-00
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Trial Treatment · Phase 2 · Zenas Biopharma (USA) LLC
Neuro-logisch, Vienna
Registry updated 2026-08-27
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Stadt Wien Wiener Gesundheitsverbund, Vienna · Praxisgemeinschaft Martinstrasse, Wien
Registry updated 2026-07-30
NCT03401879
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
Trial Treatment · Medical University of Vienna
Department of Clinical Pharmacology, Medical University of Vienna, Vienna
Registry updated 2025-05-23

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error